Free Trial

EKF Diagnostics (LON:EKF) Shares Down 7% - Here's What Happened

EKF Diagnostics logo with Medical background

Key Points

  • EKF Diagnostics shares fell by 7% during mid-day trading, reaching a low of GBX 23.60 ($0.31) before closing at GBX 26 ($0.35).
  • The company reported a £116.76 million market capitalization and a price-to-earnings ratio of 19.26, with significant trading volume up 404% from the average.
  • In its last earnings report, EKF Diagnostics achieved a 0.43 EPS for the quarter and has a projected annual EPS of approximately 2.30.
  • Five stocks we like better than EKF Diagnostics.

EKF Diagnostics Holdings plc (LON:EKF - Get Free Report) shares dropped 7% during mid-day trading on Saturday . The stock traded as low as GBX 23.60 ($0.31) and last traded at GBX 26 ($0.35). Approximately 2,281,890 shares traded hands during trading, an increase of 404% from the average daily volume of 453,091 shares. The stock had previously closed at GBX 27.95 ($0.37).

EKF Diagnostics Trading Down 7.0%

The company has a market capitalization of £116.76 million, a price-to-earnings ratio of 19.26 and a beta of 0.57. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.77 and a current ratio of 4.60. The firm has a fifty day moving average price of GBX 29.18 and a 200-day moving average price of GBX 26.59.

EKF Diagnostics (LON:EKF - Get Free Report) last released its earnings results on Tuesday, September 16th. The company reported GBX 0.43 earnings per share (EPS) for the quarter. EKF Diagnostics had a return on equity of 7.03% and a net margin of 9.37%. As a group, equities analysts anticipate that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current year.

About EKF Diagnostics

(Get Free Report)

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in EKF Diagnostics Right Now?

Before you consider EKF Diagnostics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EKF Diagnostics wasn't on the list.

While EKF Diagnostics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for November 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.